Suppr超能文献

胰十二指肠切除术后淋巴结参数对远端胆管癌的预后影响

Prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy.

作者信息

Lyu Shaocheng, Li Lixin, Zhao Xin, Ren Zhangyong, Cao Di, He Qiang

机构信息

Department of Hepatobiliary Surgery, Beijing Chaoyang Hospital, Capital Medical University, 8 Gongtinan Road, Chaoyang District, Beijing, 100020, China.

出版信息

World J Surg Oncol. 2020 Oct 8;18(1):262. doi: 10.1186/s12957-020-02040-1.

Abstract

BACKGROUND

Pancreaticoduodenectomy is the only definitively curative therapy for the long-term survival of distal cholangiocarcinoma patients. Lymph node metastasis is widely accepted as an important prognostic factor for distal cholangiocarcinoma. The latest American Joint Committee on Cancer (AJCC) TNM classification system for distal cholangiocarcinoma has divided the lymph node metastasis patients into N1 and N2 by lymph node metastasis number. However, some studies suggested that the lymph node metastasis ratio may be better than the lymph node metastasis number. Therefore, we develop a program to analyze the correlation between lymph node parameters (lymph node dissection number, lymph node metastasis number, and lymph node metastasis rate) and long-term prognosis.

METHODS

We retrospectively reviewed 123 distal cholangiocarcinoma patients after pancreatoduodenectomy from January 2011 to December 2019. The patients were grouped according to lymph node metastases and tumor-free and overall survival rates which were investigated with the Kaplan-Meier analysis. The logistic regression models were used for multivariate analysis to determine the risk factors for lymph node metastases. And the X-tile program was used to calculate the cutoff values for the lymph node parameters that discriminated survival.

RESULTS

The 1-year, 3-year, and 5-year overall survival rates of patients with distal cholangiocarcinoma after pancreatoduodenectomy were 75.2%, 37.1%, and 31.5%, respectively. And the 1-year, 3-year, and 5-year overall survival rates of patients without and with lymph node metastasis were 83.0%, 50.7%, and 42.5% and 63.5%, 19.0%, and 19.0% (p = 0.000), respectively. Logistic regression showed CA19-9 and portal vein system invasion as independent risk factors for lymph node metastases. The receiver operating characteristic curve showed the optimal cutoff value of CA19-9 to predict the lymph node metastases was 75.5 U/mL. Determined by the X-tile software, the optimal cutoff values of the lymph node dissection number were 24 (p = 0.021), the lymph node metastasis number were 1 and 7 (p = 0.504), and the lymph node metastasis rate were 0.13 (p = 0.002).

CONCLUSION

Lymph node metastasis is an important factor affecting the long-term survival of distal cholangiocarcinoma patients.CA19-9 and portal vein system invasion are independent risk factors for lymph node metastasis. Besides, the lymph node dissection number and lymph node metastasis rate can predict the long-term survival better than lymph node metastasis number.

摘要

背景

胰十二指肠切除术是远端胆管癌患者长期生存的唯一确定性治愈性疗法。淋巴结转移被广泛认为是远端胆管癌的一个重要预后因素。美国癌症联合委员会(AJCC)最新的远端胆管癌TNM分类系统根据淋巴结转移数量将淋巴结转移患者分为N1和N2。然而,一些研究表明淋巴结转移率可能比淋巴结转移数量更好。因此,我们开发了一个程序来分析淋巴结参数(淋巴结清扫数量、淋巴结转移数量和淋巴结转移率)与长期预后之间的相关性。

方法

我们回顾性分析了2011年1月至2019年12月期间123例行胰十二指肠切除术后的远端胆管癌患者。根据淋巴结转移情况对患者进行分组,并采用Kaplan-Meier分析方法研究无瘤生存率和总生存率。采用逻辑回归模型进行多因素分析以确定淋巴结转移的危险因素。并使用X-tile程序计算区分生存情况的淋巴结参数的截断值。

结果

远端胆管癌患者胰十二指肠切除术后1年、3年和5年的总生存率分别为75.2%、37.1%和31.5%。无淋巴结转移和有淋巴结转移患者的1年、3年和5年总生存率分别为83.0%、50.7%、42.5%和63.5%、19.0%、19.0%(p = 0.000)。逻辑回归显示CA19-9和门静脉系统侵犯是淋巴结转移的独立危险因素。受试者工作特征曲线显示预测淋巴结转移的CA19-9最佳截断值为75.5 U/mL。由X-tile软件确定,淋巴结清扫数量的最佳截断值为24(p = 0.021),淋巴结转移数量为1和7(p = 0.504),淋巴结转移率为0.13(p = 0.002)。

结论

淋巴结转移是影响远端胆管癌患者长期生存的重要因素。CA19-9和门静脉系统侵犯是淋巴结转移的独立危险因素。此外,淋巴结清扫数量和淋巴结转移率比淋巴结转移数量能更好地预测长期生存情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b4/7545845/9823eaa2f70e/12957_2020_2040_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验